Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Arch Oral Biol. 2015 Dec 3;63:82–92. doi: 10.1016/j.archoralbio.2015.11.021

Fig. 1.

Fig. 1

(A) Biglycan and (B) fibromodulin regardless of the type of cementum (secondary cementum-SC in (A); primary cementum–PC in (B)) were immunolocalized. PDL-inserts contained biglycan (between solid arrows) as it transitioned from the PDL-space into bulk cementum and coursed through cementum (asterisks) up to the CDJ (A–C). A negative control is shown in (D).